Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): A randomised, open-label, non-comparative phase 2 trial
David Malka, Pascale Cervera, Stéphanie Foulon, Tanja Trarbach, Christelle de la Fouchardière, Eveline Boucher, Laetitia Fartoux, Sandrine Faivre, Jean Frédéric Blanc, Frédéric Viret, Eric Assenat, Thomas Seufferlein, Thomas Herrmann, Julien Grenier, Pascal Hammel, Matthias Dollinger, Thierry André, Philipp Hahn, Volker Heinemann, Vanessa RousseauMichel Ducreux, Jean Pierre Pignon, Dominique Wendum, Olivier Rosmorduc, Tim F. Greten
Research output: Contribution to journal › Article › peer-review
334Scopus
citations
Fingerprint
Dive into the research topics of 'Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): A randomised, open-label, non-comparative phase 2 trial'. Together they form a unique fingerprint.